skip to content
Basal-Bolus versus sliding-scale insulin therapy in the acute care hospital setting : a review of comparative clinical effectiveness and cost-effectiveness Preview this item
ClosePreview this item
Checking...

Basal-Bolus versus sliding-scale insulin therapy in the acute care hospital setting : a review of comparative clinical effectiveness and cost-effectiveness

Author: Canadian Agency for Drugs and Technologies in Health,
Publisher: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 20 January 2017.
Series: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Edition/Format:   eBook : Document : National government publication : English
Summary:
When patients with diabetes are hospitalized, their glucose control may be suboptimal because oral medications are often stopped on admission. 1 In fact, high blood sugar levels, or hyperglycemia, are common among hospitalized patients2 and linked to complications, such as increased morbidity, mortality, and hospital stay. 3 Although low blood sugar levels, or hypoglycemia are serious risks associated with insulin  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Review
Electronic books
Material Type: Document, Government publication, National government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Canadian Agency for Drugs and Technologies in Health,
OCLC Number: 1001209671
Notes: "CADTH Rapid Response Service."
Description: 1 online resource (1 PDF file (21 pages)) : illustrations.
Series Title: Rapid response report (Canadian Agency for Drugs and Technologies in Health)
Responsibility: prepared by Canadian Agency for Drugs and Technologies in Health.

Abstract:

When patients with diabetes are hospitalized, their glucose control may be suboptimal because oral medications are often stopped on admission. 1 In fact, high blood sugar levels, or hyperglycemia, are common among hospitalized patients2 and linked to complications, such as increased morbidity, mortality, and hospital stay. 3 Although low blood sugar levels, or hypoglycemia are serious risks associated with insulin therapy, potentially leading to arrhythmias and other cardiac events,2,4 better glucose control with insulin for both type 1 and type 2 diabetes may improve clinical outcomes and prevent complications in hospitals. 3 Hyperglycemia occurring during hospital stay was traditionally controlled, using sliding-scale insulin therapy, consisting of the administration of regular or rapid-acting insulin approximately five to 30 minutes before meals, based on before-meal measurements of capillary blood glucose. 3,5 Basal-bolus insulin therapy more closely mimics physiological insulin secretion, where pancreatic beta cells release insulin continuously to maintain basal metabolic glucose regulation and extra insulin in response to meals,2 and is recommended today. 3 In basal-bolus insulin therapy, a patient would be given a basal (long-acting) insulin once or twice daily, a nutritional (short- or rapid-acting) insulin before meals, and a correctional (short- or rapid-acting) insulin for any unanticipated before-meal hyperglycemia. 2 Long-acting insulins include detemir and glargine,4,5 and short-acting insulins include aspart and glulisine. 5 There are also intermediate-acting insulins, such as neutral protamine Hagedorn (NPH).4 Despite its inconsistency with physiological insulin secretion, sliding-scale insulin therapy continues to be widely used today because of its simplicity and convenience. 3,5 The purpose of this report is to provide evidence on the clinical benefits and harms and cost-effectiveness of basal-bolus versus sliding-scale insulin therapy for adult patients with type 1 or type 2 diabetes in the acute care hospital setting.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1001209671> # Basal-Bolus versus sliding-scale insulin therapy in the acute care hospital setting : a review of comparative clinical effectiveness and cost-effectiveness
    a schema:Book, schema:CreativeWork, schema:MediaObject ;
    library:oclcnum "1001209671" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/onc> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/4461334551#Place/canada> ; # Canada.
    schema:about <http://experiment.worldcat.org/entity/work/data/4461334551#Topic/cost_benefit_analysis> ; # Cost-Benefit Analysis
    schema:about <http://experiment.worldcat.org/entity/work/data/4461334551#Topic/critical_care> ; # Critical Care
    schema:about <http://experiment.worldcat.org/entity/work/data/4461334551#Topic/diabetes_mellitus_drug_therapy> ; # Diabetes Mellitus--drug therapy
    schema:about <http://experiment.worldcat.org/entity/work/data/4461334551#Topic/insulin_infusion_systems> ; # Insulin Infusion Systems
    schema:about <http://experiment.worldcat.org/entity/work/data/4461334551#Topic/treatment_outcome> ; # Treatment Outcome
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/4461334551#Organization/canadian_agency_for_drugs_and_technologies_in_health> ; # Canadian Agency for Drugs and Technologies in Health,
    schema:datePublished "2017" ;
    schema:description "When patients with diabetes are hospitalized, their glucose control may be suboptimal because oral medications are often stopped on admission. 1 In fact, high blood sugar levels, or hyperglycemia, are common among hospitalized patients2 and linked to complications, such as increased morbidity, mortality, and hospital stay. 3 Although low blood sugar levels, or hypoglycemia are serious risks associated with insulin therapy, potentially leading to arrhythmias and other cardiac events,2,4 better glucose control with insulin for both type 1 and type 2 diabetes may improve clinical outcomes and prevent complications in hospitals. 3 Hyperglycemia occurring during hospital stay was traditionally controlled, using sliding-scale insulin therapy, consisting of the administration of regular or rapid-acting insulin approximately five to 30 minutes before meals, based on before-meal measurements of capillary blood glucose. 3,5 Basal-bolus insulin therapy more closely mimics physiological insulin secretion, where pancreatic beta cells release insulin continuously to maintain basal metabolic glucose regulation and extra insulin in response to meals,2 and is recommended today. 3 In basal-bolus insulin therapy, a patient would be given a basal (long-acting) insulin once or twice daily, a nutritional (short- or rapid-acting) insulin before meals, and a correctional (short- or rapid-acting) insulin for any unanticipated before-meal hyperglycemia. 2 Long-acting insulins include detemir and glargine,4,5 and short-acting insulins include aspart and glulisine. 5 There are also intermediate-acting insulins, such as neutral protamine Hagedorn (NPH).4 Despite its inconsistency with physiological insulin secretion, sliding-scale insulin therapy continues to be widely used today because of its simplicity and convenience. 3,5 The purpose of this report is to provide evidence on the clinical benefits and harms and cost-effectiveness of basal-bolus versus sliding-scale insulin therapy for adult patients with type 1 or type 2 diabetes in the acute care hospital setting."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/4461334551> ;
    schema:genre "Review"@en ;
    schema:genre "National government publication"@en ;
    schema:genre "Government publication"@en ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/4461334551#Series/rapid_response_report_canadian_agency_for_drugs_and_technologies_in_health> ; # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/4461334551#Series/rapid_response_report_summary_with_critical_appraisal> ; # Rapid response report: summary with critical appraisal
    schema:name "Basal-Bolus versus sliding-scale insulin therapy in the acute care hospital setting : a review of comparative clinical effectiveness and cost-effectiveness"@en ;
    schema:productID "1001209671" ;
    schema:url <http://proxy.library.brocku.ca/login?url=http://books.scholarsportal.info/viewdoc.html?id=/ebooks/ebooks0/gibson_cppc-chrc/2017-10-02/8/10089885> ;
    schema:url <http://www.ncbi.nlm.nih.gov/books/NBK442094/> ;
    schema:url <https://www.ncbi.nlm.nih.gov/books/NBK442094> ;
    schema:url <http://www.deslibris.ca/ID/10089885> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1001209671> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/4461334551#Organization/canadian_agency_for_drugs_and_technologies_in_health> # Canadian Agency for Drugs and Technologies in Health,
    a schema:Organization ;
    schema:name "Canadian Agency for Drugs and Technologies in Health," ;
    .

<http://experiment.worldcat.org/entity/work/data/4461334551#Series/rapid_response_report_canadian_agency_for_drugs_and_technologies_in_health> # Rapid response report (Canadian Agency for Drugs and Technologies in Health)
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1001209671> ; # Basal-Bolus versus sliding-scale insulin therapy in the acute care hospital setting : a review of comparative clinical effectiveness and cost-effectiveness
    schema:name "Rapid response report (Canadian Agency for Drugs and Technologies in Health)" ;
    .

<http://experiment.worldcat.org/entity/work/data/4461334551#Series/rapid_response_report_summary_with_critical_appraisal> # Rapid response report: summary with critical appraisal
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1001209671> ; # Basal-Bolus versus sliding-scale insulin therapy in the acute care hospital setting : a review of comparative clinical effectiveness and cost-effectiveness
    schema:name "Rapid response report: summary with critical appraisal" ;
    .

<http://experiment.worldcat.org/entity/work/data/4461334551#Topic/cost_benefit_analysis> # Cost-Benefit Analysis
    a schema:Intangible ;
    schema:name "Cost-Benefit Analysis"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4461334551#Topic/diabetes_mellitus_drug_therapy> # Diabetes Mellitus--drug therapy
    a schema:Intangible ;
    schema:name "Diabetes Mellitus--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4461334551#Topic/insulin_infusion_systems> # Insulin Infusion Systems
    a schema:Intangible ;
    schema:name "Insulin Infusion Systems"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4461334551#Topic/treatment_outcome> # Treatment Outcome
    a schema:Intangible ;
    schema:name "Treatment Outcome"@en ;
    .

<http://www.deslibris.ca/ID/10089885>
    rdfs:comment "Access restricted: SMU users only" ;
    rdfs:comment "Access restricted: STFX users only" ;
    rdfs:comment "Access restricted: DAL users only" ;
    rdfs:comment "Access restricted: CBU users only" ;
    rdfs:comment "eBook available for Durham College via DesLibris. Click link to access" ;
    .

<http://www.worldcat.org/title/-/oclc/1001209671>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/1001209671> ; # Basal-Bolus versus sliding-scale insulin therapy in the acute care hospital setting : a review of comparative clinical effectiveness and cost-effectiveness
    schema:dateModified "2018-10-02" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.